NYSE:RCUS   Arcus Biosciences, Inc.
Phase 2 data expected 2Q 2021 based on BioPharm catalyst website. Gilead have been buying as well as another insider. Watch for a break of 36.13. Stop signal 26.44. Momentum target.

Like what you see? Get full access to our 3X daily members only video/txt alerts & live trading room at www.smartmoneytrading.com/now

Check out some of our free video examples @ smartmoneytrading.com/insights/
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。